Premium
PHASE IIIB STUDY OF LENALIDOMIDE PLUS RITUXIMAB FOLLOWED BY MAINTENANCE IN RELAPSED OR REFRACTORY NHL: ANALYSIS OF MARGINAL ZONE LYMPHOMA
Author(s) -
Coleman M.,
Andorsky D.J.,
Yacoub A.,
Melear J.M.,
Kolibaba K.S.,
Brooks H.D.,
Bitran J.D.,
Fanning S.R.,
Lansigan F.,
Ricker J.L.,
Foon K.A.,
Llorente M.,
Li J.,
Sharman J.P.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_138
Subject(s) - rituximab , medicine , lenalidomide , mantle cell lymphoma , follicular lymphoma , marginal zone b cell lymphoma , gastroenterology , phases of clinical research , lymphoma , clinical endpoint , chemotherapy regimen , oncology , multiple myeloma , chemotherapy , marginal zone , immunology , clinical trial , b cell , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom